Form 4: Curis Inc. Director John Hohneker Reports Stock Option Grant
Statement of Changes in Beneficial Ownership
Curis Inc. director John Hohneker has been granted a non-qualified stock option for 6,800 shares with an exercise price of $5.29, vesting fully on July 7, 2027.
Summary
- John Hohneker, a Director at Curis Inc. (CRIS), received a grant of 6,800 non-qualified stock options on July 7, 2026.
- The exercise price for these options is $5.29 per share.
- The options are set to vest 100% on July 7, 2027.
- The underlying securities are common stock of Curis Inc.
- This transaction is reported under Section 16(a) of the Securities Exchange Act of 1934.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock option grant to a director rather than a significant new development or financial result.
Positives
- Director compensation through stock options aligns management interests with shareholder value.
- The grant of options indicates continued confidence in the company's future prospects by a key insider.
Risks
- The value of the stock options is subject to market fluctuations and the company's performance.
- If the stock price does not exceed the exercise price of $5.29, the options may not be exercised profitably.
Future Outlook
The stock options granted are exercisable and vest in the future, indicating a forward-looking compensation strategy tied to the company's performance.
Industry Context
StockSavvy.ai notes that stock option grants to directors are a common practice in the biotechnology and pharmaceutical sectors, aligning executive incentives with long-term company growth and shareholder returns.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | John Hohneker has appointed attorneys-in-fact to execute Forms 3, 4, and 5 on his behalf. | 04/24/2026 | Facilitates timely and accurate reporting of beneficial ownership changes as required by Section 16 of the Exchange Act. |
Stakeholder Impact
- Shareholders: The option grant aligns director incentives with long-term shareholder value creation.
- Employees: May signal continued investment in key personnel and leadership.
- Management: Standard compensation practice, reinforcing the link between performance and reward.
Next Steps
- The stock options will vest on July 7, 2027.
- John Hohneker may exercise the options after vesting, subject to market conditions and company performance.
Key Dates
| Date | Description |
|---|---|
| 04/24/2026 | Date of execution of Power of Attorney by John A. Hohneker. |
| 07/06/2026 | Date exercisable for the stock option. |
| 07/07/2026 | Transaction date for the stock option grant. |
| 07/07/2027 | Full vesting date for the stock option grant. |
| 07/09/2026 | Date of signature for the Form 4 filing. |
Keywords
Curis Inc., CRIS, Form 4, Stock Option, Director, Insider Trading, SEC Filing, Beneficial Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.